Bookbuilding IPO | ₹479 Cr | Listed at BSE, NSE | Wed, Apr 27, 2016 - Fri, Apr 29, 2016
Thyrocare Technologies IPO is a book build issue of ₹479.21 crores. The issue is entirely an offer for sale of 1.07 crore shares of ₹479.21 crore.
Thyrocare Technologies IPO bidding started from Apr 27, 2016 and ended on Apr 29, 2016. The shares got listed on BSE, NSE on May 9, 2016.
Thyrocare Technologies IPO price band is set at ₹446 per share. The lot size for an application is 33. The minimum amount of investment required by an retail is ₹14,718 (33 shares) (based on upper price). The lot size investment for sNII is 14 lots (462 shares), amounting to ₹2,06,052, and for bNII, it is 68 lots (2,244 shares), amounting to ₹10,00,824.
Edelweiss Financial Services Ltd. is the book running lead manager and MUFG Intime India Pvt.Ltd. is the registrar of the issue.
Refer to Thyrocare Technologies IPO RHP for detailed Information.
IPO Open
Wed, Apr 27, 2016
IPO Close
Fri, Apr 29, 2016
Issue Price
₹446 per share
Market Cap (Pre-IPO)
₹2,396.07 Cr
| IPO Date | 27 to 29 Apr, 2016 |
| Listed on | Mon, May 9, 2016 |
| Face Value | ₹10 per share |
| Price Band | ₹420 to ₹446 |
| Issue Price | ₹446 per share |
| Lot Size | 33 Shares |
| Sale Type | OFS only |
| Issue Type | Bookbuilding IPO |
| Listing At | BSE, NSE |
| Total Issue Size | 1,07,44,708 shares (agg. up to ₹479 Cr) |
| Offer for Sale | 1,07,44,708 shares of ₹10 (agg. up to ₹479 Cr) |
| Share Holding Pre Issue | 5,37,23,533 shares |
| Share Holding Post Issue | 5,37,23,533 shares |
| BSE Script Code / NSE Symbol | 539871 / THYROCARE |
| ISIN | INE594H01019 |
Thyrocare Technologies IPO comprises a total issue size of 1,07,44,708 shares. Out of which, 53,72,353 (50.00%) are allocated to QIB, 16,11,707 (15.00%) allocated to NII 37,60,648 (35.00%) allocated to RII.
| Investor Category | Shares Offered | % of Total Issue | Max Allottees |
|---|---|---|---|
| QIB Shares Offered | 53,72,353 | 50.00% | NA |
| − Anchor Investor Shares Offered | 32,23,411 | 30.00% | NA |
| − QIB (Ex. Anchor) Shares Offered | 21,48,942 | 20.00% | NA |
| NII (HNI) Shares Offered | 16,11,707 | 15.00% | NA |
| Retail Shares Offered | 37,60,648 | 35.00% | 1,13,959 |
| Total Shares Offered | 1,07,44,708 | 100.00% |
Investors can bid for a minimum of 33 shares and in multiples thereof.
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 1 | 33 | ₹14,718 |
| Retail (Max) | 13 | 429 | ₹1,91,334 |
| S-HNI (Min) | 14 | 462 | ₹2,06,052 |
| S-HNI (Max) | 67 | 2,211 | ₹9,86,106 |
| B-HNI (Min) | 68 | 2,244 | ₹10,00,824 |
Incorporated in 2000, Thyrocare Technologie Ltd is one of the leading pan-India diagnostic chains and conduct an array of medical diagnostic tests and profiles of tests that helps in early detection and management of disorders and diseases.
They are India's first fully automated diagnostic laboratory having its strong presence in more than 2000 cities / towns in India and internationally. As of November 30, 2015, they offered 192 tests and 54 profiles of tests to detect a number of disorders, including thyroid disorders, growth disorders, metabolism disorders, auto-immunity, diabetes, anemia, cardiovascular disorders, infertility and various infectious diseases.
Their laboratory process over 30,000 sample and above 1 lakh investigations every day. Their profiles of tests include 17 profiles of tests administered under their 'Aarogyam' brand. Through wholly owned subsidiary, NHL, they operate a network of molecular imaging centers in New Delhi, Navi Mumbai and Hyderabad, focused on early and effective cancer monitoring.
| Period Ended |
|---|
| Amount in ₹ Crore |
| KPI | |
|---|---|
| RoNW | 17.37% |
| Pre IPO | Post IPO | |
|---|---|---|
| Promoter Holding | 64.96% | 63.96% |
| Market Cap | ₹2,396.07 Cr. |
The Thyrocare Technologies IPO is subscribed 73.55 times on April 29, 2016 11:15:00 PM (Day 3). The public issue subscribed 8.73 times in the retail category, 73.18 times in the QIB category, and 225.3 times in the NII category. Check Day by Day Subscription Details (Live Status)
| Category | Subscription (times) | Shares Offered | Shares bid for |
|---|---|---|---|
| QIB | 73.18 | 21,48,942 | |
| NII | 225.3 | 16,11,707 | |
| Retail | 8.73 | 37,60,648 | |
| Total | 73.55 | 75,21,297 |
| # | Issue Expenses | Est Amt (₹ Cr.) |
|---|---|---|
| 1 | Fees payable to BRLMs | 10.99 |
| 2 | Selling commission and processing fees for SCSBs | 0.68 |
| 3 | Selling commission and bidding charges for the Syndicate Members, Registered Brokers, RTAs and CDPs | 0.84 |
| 4 | Fees payable to Registrar to the Offer | 0.02 |
| 5 | Printing and stationary expenses | 1.42 |
| 6 | Advertising and marketing expenses | 9.44 |
| 7 | Listing fees | 0.07 |
| 8 | SEBI, BSE and NSE processing fees | 1.38 |
| 9 | Fees payable to Legal Counsels | 4.16 |
| 10 | Miscellaneous | 3.72 |
| Price Details | BSE | NSE |
|---|---|---|
| Final Issue Price | ₹446.00 | ₹446.00 |
| Open | ₹662.00 | ₹665.00 |
| Low | ₹606.00 | ₹605.80 |
| High | ₹665.40 | ₹665.00 |
| Last Trade | ₹618.10 | ₹618.80 |
Thyrocare Technologies IPO is a main-board IPO of 1,07,44,708 equity shares of the face value of ₹10 aggregating up to ₹479 Crores. The issue is priced at ₹446 per share. The minimum order quantity is 33.
The IPO opens on Wed, Apr 27, 2016, and closes on Fri, Apr 29, 2016.
MUFG Intime India Pvt.Ltd. is the registrar for the IPO. The shares are proposed to be listed on BSE, NSE.
Zerodha customers can apply online in Thyrocare Technologies IPO using UPI as a payment gateway. Zerodha customers can apply in Thyrocare Technologies IPO by login into Zerodha Console (back office) and submitting an IPO application form.
Steps to apply in Thyrocare Technologies IPO through Zerodha
Visit Zerodha IPO Application Process Review for more detail.
The Thyrocare Technologies IPO opens on Wed, Apr 27, 2016 and closes on Fri, Apr 29, 2016.
Thyrocare Technologies IPO lot size is 33, and the minimum amount required for application is ₹14,718.
You can apply in Thyrocare Technologies IPO online using either UPI or ASBA as a payment method. ASBA IPO application is available in the net banking of your bank account. UPI IPO Application is offered by brokers who don't offer banking services. Read more detail about applying IPO online through Zerodha, Upstox, 5Paisa, Nuvama, HDFC Bank, and SBI Bank.
The finalization of Basis of Allotment for Thyrocare Technologies IPO will be done on [.], and the allotted shares will be credited to your demat account by . Check the Thyrocare Technologies IPO allotment status.
The Thyrocare Technologies IPO listing date is on Mon, May 9, 2016.
